CEA-based vaccines

Emina H Huang1, Howard L Kaufman

  • 1Department of Surgery, College of Physicians & Surgeons, Columbia University, New York, NY, USA.

Insights

Carcinoembryonic antigen (CEA) vaccines target tumors expressing this antigen. Early trials show these CEA-based vaccines can stimulate immune responses and are being explored for cancer treatment and prevention.

Area of Science:

  • Oncology
  • Immunology
  • Vaccine Development

Background:

  • Carcinoembryonic antigen (CEA) is a tumor-associated antigen found in nearly 50% of human tumors.
  • CEA was first cloned in 1987, establishing its significance in cancer research.

Purpose of the Study:

  • To review the development and evaluation of vaccine strategies targeting CEA and CEA-expressing tumors.
  • To discuss the role of CEA-specific immune responses and their monitoring in clinical trials.

Main Methods:

  • Identification of T-cell specific epitopes within the CEA protein.
  • Development and preclinical testing of CEA-based vaccines.
  • Evaluation of vaccine-induced immune responses in early-phase clinical trials using in vitro assays.

Main Results:

  • CEA-based vaccines have demonstrated therapeutic effectiveness in animal models.
  • Early clinical trials are assessing the safety and immunogenicity of these vaccines.
  • In vitro assays provide insights into the induction of CEA-specific immune responses.

Conclusions:

  • CEA-based vaccines show promise for cancer treatment and prevention.
  • Further clinical testing in less advanced disease and combination therapies are needed.
  • Defining the role of CEA vaccines requires continued investigation in human cancer treatment.

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

Overview
Vaccinations01:51

Vaccinations

Overview
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...